• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估 Ki67 增殖指数和肿瘤浸润淋巴细胞在嗅神经母细胞瘤中的预后潜力。

Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma.

机构信息

Department of Pathology, Institut Gustave Roussy, Villejuif, France.

Department of Otolaryngology - Head and Neck Surgery, Assistance Publique-Hopitaux de Paris, Lariboisière Hospital, Paris, France.

出版信息

Histopathology. 2019 Dec;75(6):853-864. doi: 10.1111/his.13954. Epub 2019 Oct 6.

DOI:10.1111/his.13954
PMID:31306501
Abstract

AIMS

Olfactory neuroblastomas (ONBs) are rare malignant tumours that arise in the nasal vault. To date, the Hyams grade remains the only widely used histological grading system. However, it is based only on morphological criteria, and has not been updated since 1988. The objective of this study was to explore the prognostic potential of the Ki67 proliferation index (PI) and tumour-infiltrating lymphocytes (TILs) in ONB.

METHODS AND RESULTS

A retrospective study was conducted on a bicentric series of 45 cases. The Ki67 PI was determined by counting at least 1000 nuclei on whole slides. TILs were evaluated with CD20, CD4 and CD8 immunohistochemical markers on whole slides. In this series, Hyams grades I, II, III and IV accounted for 13.4%, 44.4%, 20% and 22.2% of all cases, respectively. The Ki67 PI ranged from 1 to 93; the Ki67 PI was significantly higher in Hyams grade III-IV ONBs than in Hyams grade I-II ONBs (P < 0.0001). A Ki67 PI of ≥25 was associated with poorer survival (P = 0.02). TILs were present in both stromal and intratumoral compartments, but were located predominantly in the stromal component of the tumour. The numbers of intratumoral CD8+ cells/mm and CD4+ cells/mm were greater in high-grade ONBs than in low-grade ONBs (P = 0.0015 and P = 0.043, respectively). The numbers of T cells/mm and B cells/mm were not associated with survival, but a CD4/CD8 ratio of >2 was significantly associated with shorter survival (P = 0.04).

CONCLUSION

Our findings suggest that the Ki67 PI and TILs could be used as prognostic markers, as a potential alternative to the Hyams grade.

摘要

目的

嗅神经母细胞瘤(ONB)是一种罕见的恶性肿瘤,起源于鼻腔穹窿。迄今为止,Hyams 分级仍然是唯一广泛使用的组织学分级系统。然而,它仅基于形态学标准,自 1988 年以来并未更新。本研究的目的是探讨 Ki67 增殖指数(PI)和肿瘤浸润淋巴细胞(TILs)在 ONB 中的预后潜力。

方法和结果

对两个中心的 45 例病例进行了回顾性研究。通过在整个幻灯片上计数至少 1000 个细胞核来确定 Ki67 PI。TILs 用 CD20、CD4 和 CD8 免疫组化标志物在整个幻灯片上进行评估。在本系列中,Hyams 分级 I、II、III 和 IV 分别占所有病例的 13.4%、44.4%、20%和 22.2%。Ki67 PI 范围为 1 至 93;Hyams 分级 III-IV ONB 的 Ki67 PI 明显高于 Hyams 分级 I-II ONB(P<0.0001)。Ki67 PI≥25 与生存率较差相关(P=0.02)。TILs 存在于基质和肿瘤内部位,但主要位于肿瘤的基质成分中。高分级 ONB 的肿瘤内 CD8+细胞/mm 和 CD4+细胞/mm 数量高于低分级 ONB(P=0.0015 和 P=0.043)。T 细胞/mm 和 B 细胞/mm 的数量与生存率无关,但 CD4/CD8 比值>2 与生存率较短显著相关(P=0.04)。

结论

我们的研究结果表明,Ki67 PI 和 TILs 可用作预后标志物,作为替代 Hyams 分级的潜在方法。

相似文献

1
Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma.评估 Ki67 增殖指数和肿瘤浸润淋巴细胞在嗅神经母细胞瘤中的预后潜力。
Histopathology. 2019 Dec;75(6):853-864. doi: 10.1111/his.13954. Epub 2019 Oct 6.
2
Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.嗅神经母细胞瘤(ONB)及鼻腔鼻窦神经内分泌肿瘤中转录因子表达:Hyams grade 1-3 的嗅神经母细胞瘤扩大了 SATB2 和 GATA3 阳性肿瘤谱。
Endocr Pathol. 2022 Jun;33(2):264-273. doi: 10.1007/s12022-022-09715-3. Epub 2022 May 6.
3
Clincopathological analysis of olfactory neuroblastoma.嗅神经母细胞瘤的临床病理分析。
Brain Tumor Pathol. 2012 Oct;29(4):207-15. doi: 10.1007/s10014-012-0083-3. Epub 2012 Feb 14.
4
Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?嗅神经母细胞瘤中的微血管密度和Ki-67标记指数:是否具有预后作用?
Ann Diagn Pathol. 2015 Dec;19(6):391-6. doi: 10.1016/j.anndiagpath.2015.06.008. Epub 2015 Jul 18.
5
The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.嗅神经母细胞瘤和鼻内神经内分泌肿瘤的临床病理谱:诊断标准的细化以及多模态治疗对生存的影响。
Oral Oncol. 2017 Nov;74:21-29. doi: 10.1016/j.oraloncology.2017.09.010.
6
Prognostic significance of PD-1, CTLA-4, CD4, and CD8 expression in olfactory neuroblastoma.PD-1、CTLA-4、CD4和CD8表达在嗅神经母细胞瘤中的预后意义
Clin Neuropathol. 2023 Mar-Apr;42(2):47-53. doi: 10.5414/NP301519.
7
Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.嗅神经母细胞瘤和鼻窦未分化癌:组织学分级和临床分期对生存及预后的影响
Laryngoscope. 2000 Aug;110(8):1262-5. doi: 10.1097/00005537-200008000-00007.
8
Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature.嗅神经母细胞瘤中生长抑素受体 2a 的频繁表达:一个新的、独特的特征。
Hum Pathol. 2018 Sep;79:144-150. doi: 10.1016/j.humpath.2018.05.013. Epub 2018 May 25.
9
[New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].[结合海姆斯分级系统和改良卡迪什分期评估嗅神经母细胞瘤进展的新系统]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Jul;33(7):599-602. doi: 10.13201/j.issn.1001-1781.2019.07.006.
10
Clinical features and the molecular biomarkers of olfactory neuroblastoma.嗅神经母细胞瘤的临床特征与分子生物标志物
Pathol Res Pract. 2018 Aug;214(8):1123-1129. doi: 10.1016/j.prp.2018.06.002. Epub 2018 Jun 10.

引用本文的文献

1
Hypoosmolar Hyponatremia as Presenting Symptom of a Rare Case of Olfactory Neuroblastoma.低渗性低钠血症作为罕见嗅神经母细胞瘤病例的首发症状
JCEM Case Rep. 2025 Jun 23;3(8):luaf130. doi: 10.1210/jcemcr/luaf130. eCollection 2025 Aug.
2
Forty-Year Long-Term Outcome After Endoscopic and Open Surgery for Esthesioneuroblastoma in Consideration of Prognostic Factors.考虑预后因素的嗅神经母细胞瘤内镜手术和开放手术后40年长期结果
Cancers (Basel). 2025 Jan 21;17(3):343. doi: 10.3390/cancers17030343.
3
PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop.
PD-1 和 CTLA-4 作为主要的守门员,通过限制 CXCL9/10-CXCR3-IFNγ 正反馈回路,增强效应器和细胞毒性 T 细胞的作用。
Front Immunol. 2024 Oct 15;15:1452212. doi: 10.3389/fimmu.2024.1452212. eCollection 2024.
4
Survival Analysis and Prognostic Factors After Endonasal Resection of Advanced Olfactory Neuroblastomas: A Single Institution Experience.嗅神经母细胞瘤内镜手术后的生存分析和预后因素:单中心经验
J Otolaryngol Head Neck Surg. 2024 Jan-Dec;53:19160216241267737. doi: 10.1177/19160216241267737.
5
Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses.肿瘤 HLA-DR、CXCL9 和 CXCL10 的表达增强可能改善嗅神经母细胞瘤的免疫治疗反应。
J Transl Med. 2024 May 31;22(1):524. doi: 10.1186/s12967-024-05339-9.
6
Genomic profiling and immune landscape of olfactory neuroblastoma in China.中国嗅神经母细胞瘤的基因组图谱与免疫格局
Front Oncol. 2023 Nov 1;13:1226494. doi: 10.3389/fonc.2023.1226494. eCollection 2023.
7
Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas.Sox2和βIII-微管蛋白作为低分化鼻窦癌耐药性的生物标志物
J Pers Med. 2023 Oct 18;13(10):1504. doi: 10.3390/jpm13101504.
8
Sinonasal Cancer: Improving Classification, Stratification and Therapeutic Options.鼻窦癌:改善分类、分层及治疗选择
Cancers (Basel). 2023 Mar 9;15(6):1675. doi: 10.3390/cancers15061675.
9
Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future.Ki67 增殖指数在神经内分泌和内分泌肿瘤中的诊断、预后和预测作用:过去、现在和未来。
Endocr Pathol. 2023 Mar;34(1):79-97. doi: 10.1007/s12022-023-09755-3. Epub 2023 Feb 17.
10
Biomarkers for Immunotherapy in Poorly Differentiated Sinonasal Tumors.低分化鼻窦肿瘤免疫治疗的生物标志物
Biomedicines. 2022 Sep 6;10(9):2205. doi: 10.3390/biomedicines10092205.